KIORA PHARMACEUTICALS INC Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Kiora Pharmaceuticals Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q3 2024.
  • Kiora Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$3.41M, a 40.8% increase year-over-year.
  • Kiora Pharmaceuticals Inc Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was $5.55M.
  • Kiora Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$12.5M, a 7.88% increase from 2022.
  • Kiora Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$13.6M, a 1.36% increase from 2021.
  • Kiora Pharmaceuticals Inc annual Net Income (Loss) Attributable to Parent for 2021 was -$13.8M, a 101% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $5.55M -$3.41M +$2.35M +40.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $3.2M -$2.22M +$392K +15% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-09
Q1 2024 $2.81M $13.5M +$15.3M Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-10
Q4 2023 -$12.5M -$2.27M +$230K +9.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$12.7M -$5.76M -$644K -12.6% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 -$12.1M -$2.61M -$213K -8.87% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 -$11.9M -$1.87M +$1.7M +47.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q4 2022 -$13.6M -$2.5M +$3.68M +59.6% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$17.3M -$5.12M -$2.08M -68.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$15.2M -$2.4M +$142K +5.59% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$15.3M -$3.57M -$1.55M -77.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$13.8M -$6.18M -$5M -421% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$8.77M -$3.03M -$1.03M -51.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 -$7.75M -$2.54M -$826K -48.1% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
Q1 2021 -$6.92M -$2.01M -$58.4K -2.99% Jan 1, 2021 Mar 31, 2021 10-Q 2022-07-08
Q4 2020 -$6.86M -$1.19M +$1.52M +56.1% Oct 1, 2020 Dec 31, 2020 10-K/A 2022-07-07
Q3 2020 -$8.38M -$2.01M +$1.42M +41.5% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$9.8M -$1.72M +$120K +6.54% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$9.92M -$1.95M -$2.82M -324% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 -$7.1M -$2.7M -$174K -6.88% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-25
Q3 2019 -$6.92M -$3.43M -$305K -9.75% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-09
Q2 2019 -$6.62M -$1.84M +$943K +33.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$7.56M $871K +$3.25M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q4 2018 -$10.8M -$2.53M +$303K +10.7% Oct 1, 2018 Dec 31, 2018 10-K 2020-03-04
Q3 2018 -$11.1M -$3.12M +$1.02M +24.6% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 -$12.1M -$2.78M +$547K +16.4% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$12.7M -$2.38M +$540K +18.5% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q4 2017 -$13.2M -$2.83M Oct 1, 2017 Dec 31, 2017 10-K 2019-03-01
Q3 2017 -$4.14M Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$3.33M Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-03
Q1 2017 -$2.92M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.